DK104232C - Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-Δ<4,9,11>-estratrien eller dets estere. - Google Patents

Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-Δ<4,9,11>-estratrien eller dets estere.

Info

Publication number
DK104232C
DK104232C DK183163AA DK183163A DK104232C DK 104232 C DK104232 C DK 104232C DK 183163A A DK183163A A DK 183163AA DK 183163 A DK183163 A DK 183163A DK 104232 C DK104232 C DK 104232C
Authority
DK
Denmark
Prior art keywords
estratriene
oxo
hydroxy
esters
preparation
Prior art date
Application number
DK183163AA
Other languages
English (en)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of DK104232C publication Critical patent/DK104232C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
DK183163AA 1962-04-20 1963-04-19 Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-Δ<4,9,11>-estratrien eller dets estere. DK104232C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR895239A FR1380414A (fr) 1962-04-20 1962-04-20 Nouveaux stéroïdes estratriènes et procédé de préparation

Publications (1)

Publication Number Publication Date
DK104232C true DK104232C (da) 1966-04-25

Family

ID=8777413

Family Applications (1)

Application Number Title Priority Date Filing Date
DK183163AA DK104232C (da) 1962-04-20 1963-04-19 Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-Δ<4,9,11>-estratrien eller dets estere.

Country Status (8)

Country Link
AT (1) AT253694B (da)
BR (1) BR6348531D0 (da)
CH (1) CH414608A (da)
DK (1) DK104232C (da)
ES (1) ES287190A1 (da)
FR (2) FR1380414A (da)
GB (3) GB1035685A (da)
SE (1) SE308310B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2183555B1 (da) * 1972-05-10 1975-06-20 Roussel Uclaf
FR2388560A1 (fr) * 1977-04-27 1978-11-24 Roussel Uclaf Nouvelles compositions zootechniques renfermant d'une part le zeranol et d'autre part un steroide 4,9,11 trienique
JP3014784B2 (ja) * 1991-02-13 2000-02-28 日本ユクラフ株式会社 魚類のストレス防止用薬剤
FR2674436B1 (fr) * 1991-03-28 1995-01-20 Roussel Uclaf Nouvelle utilisation de sterouides 4,9,11-trieniques dans des compositions destinees a l'administration chez la dinde.
EP4001288A1 (en) * 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit
ES2948624T3 (es) * 2020-11-19 2023-09-14 Fis Fabbrica Italiana Sintetici Spa Proceso mejorado para la preparación de trembolona y/o acetato de trembolona
EP4000688A1 (en) * 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution

Also Published As

Publication number Publication date
FR1958M (fr) 1963-08-05
FR1380414A (fr) 1964-12-04
ES287190A1 (es) 1963-06-01
SE308310B (da) 1969-02-10
AT253694B (de) 1967-04-25
GB1035685A (en) 1966-07-13
GB1035684A (en) 1966-07-13
GB1035683A (en) 1966-07-13
BR6348531D0 (pt) 1973-07-03
CH414608A (fr) 1966-06-15

Similar Documents

Publication Publication Date Title
DK127062B (da) Analogifremgangsmåde til fremstilling af 18-nor-13β-ethyl-estradiol eller dets estere.
DK104232C (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-Δ&lt;4,9,11&gt;-estratrien eller dets estere.
DK107742C (da) Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2&#39;-carboxyethyl)-7aβ-methyl-5,6,7,7a-tetrahydroindan eller estere deraf.
DK115537B (da) Fremgangsmåde til fremstilling af 6-methyl-Δ&lt;8,9&gt;-ergolen-8-carboxylsyre eller lysergsyre.
DK102858C (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-10β-allyl-Δ&lt;4,9(11)&gt;-estradien eller dets estere.
DK127598B (da) Analogifremgangsmåde til fremstilling af 17-halogenalkynyl-3,17-dihydroxy-13-ethylgonener eller -D-homogener eller estere eller ethere deraf.
DK103396C (da) Fremgangsmåde til fremstilling af estere af 17α-ethynyl-5(10)-estren-3β,17β-diol.
DK111487B (da) Fremgangsmåde til fremstilling af 17β-hydroxy- eller 17β-alkanoyloxy-3-keto-Δ&lt;4,8(14),9&gt;-gonatriener.
DK113585B (da) Analogifremgangsmåde til fremstilling af 15, 16β-methylen-3-keto-Δ&lt;4&gt;-19-nor-androsten-17β-oler eller estere deraf.
DK109329C (da) Fremgangsmåde til fremstilling af Δ&lt;4&gt;-6α-alkyl-19-nor-pregnener.
DK104303C (da) Fremgangsmåde til fremstilling af 3α-hydroxy-11-oxo-21,21-bis-(hydroxymethyl)-5β-pregnan eller estere deraf.
DK97404C (da) Fremgangsmåde til fremstilling af 3,20-diketo-11β,18-oxido-18-methyl-21-hydroxy-Δ&lt;4&gt;-pregnen eller dets estere.
DK101119C (da) Fremgangsmåde til fremstilling af 17β-hydroxy-Δ&lt;4,9&gt;-estradien-3-on eller dets estere.
DK99142C (da) Fremgangsmåde til fremstilling af 6,16α-dialkyl-17α-hydroksy-6-dehydro-progesteron eller estere deraf.
DK107296C (da) Fremgangsmåde til fremstilling af basiske 3,5-dimenthoxy-4-alkoxybenzoesyreestere.
DK103081C (da) Fremgangsmåde til fremstilling af 2,6-diketo-8-thiapuriner.
DK115852B (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxymethyl-7,8-dihydropteridin.
DK104170C (da) Fremgangsmåde til fremstilling af 3-alkoxy- eller 3-aralkoxy-16-amino-Δ&lt;3,5&gt;-pregnadien-17α-ol-20-oner, eller 16-amino-Δ&lt;4&gt;-pregnen-17α-ol-3,20-dioner.
DK103239C (da) Fremgangsmåde til fremstilling af 2,3-dicyan-1,4-dithia-anthrahydroquinon eller 2,3-dicyan-1,4-dithia-anthraquinon.
DK114827B (da) Fremgangsmåde til fremstilling af 5-keto-11-hydroxy-17β-acyloxy-Δ&lt;9&gt;-des-A-estren eller 5,11-diketo-17β-acyloxy-Δ&lt;9&gt;-des-A-estren.
DK106670C (da) Fremgangsmåde til fremstilling af Δ&lt;3&gt;-17β-hydroxy-17α-methyl-5α-androsten eller estere deraf.
DK105868C (da) Fremgangsmåde til fremstilling af Δ&lt;4&gt;-3-keto-6α-alkyl-19-nor-pregnener eller estere deraf.
DK97402C (da) Fremgangsmåde til fremstilling af 21-hydroxy-20-hydroxymethyl-3,11-dioxo-Δ&lt;4&gt;-pregnen eller estere deraf.
DK98625C (da) Fremgangsmåde til fremstilling af 21-hydroxy-3,11-dioxo-Δ&lt;4&gt;-pregnen eller estere deraf.
DK99457C (da) Fremgangsmåde til fremstilling af 20,21-dihydroxy-3,11-dioxo-20-hydroxymethyl-Δ&lt;4&gt;-pregnen eller estere deraf.